OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision medicine: Ray of hope in overcoming cancer multidrug resistance
Pankaj Musyuni, Jing Bai, Afsana Sheikh, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100889-100889
Closed Access | Times Cited: 42
Pankaj Musyuni, Jing Bai, Afsana Sheikh, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100889-100889
Closed Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 195
Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 195
Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy
Tenzin Tsering Dongsar, Tenzin Sonam Dongsar, Neelima Gupta, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104371-104371
Closed Access | Times Cited: 51
Tenzin Tsering Dongsar, Tenzin Sonam Dongsar, Neelima Gupta, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104371-104371
Closed Access | Times Cited: 51
New opportunities for RGD-engineered metal nanoparticles in cancer
Qin Wei, Jyoti Chandra, Mohammed A. S. Abourehab, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Qin Wei, Jyoti Chandra, Mohammed A. S. Abourehab, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 17
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 17
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 3
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 3
An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis
Sahim Aziz Hazari, Harsimran Kaur, Ritu Karwasra, et al.
International Journal of Pharmaceutics (2023) Vol. 638, pp. 122938-122938
Closed Access | Times Cited: 34
Sahim Aziz Hazari, Harsimran Kaur, Ritu Karwasra, et al.
International Journal of Pharmaceutics (2023) Vol. 638, pp. 122938-122938
Closed Access | Times Cited: 34
Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells
Kornélia Szebényi, András Füredi, Eszter Bajtai, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101007-101007
Open Access | Times Cited: 31
Kornélia Szebényi, András Füredi, Eszter Bajtai, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101007-101007
Open Access | Times Cited: 31
Photoactivated DNA Nanodrugs Damage Mitochondria to Improve Gene Therapy for Reversing Chemoresistance
Danyu Wang, Yi Hua, Shizhen Geng, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16923-16934
Closed Access | Times Cited: 29
Danyu Wang, Yi Hua, Shizhen Geng, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16923-16934
Closed Access | Times Cited: 29
Self-nanoemulsifying drug delivery system for pancreatic cancer
Neha Parveen, Afsana Sheikh, Mohammed A. S. Abourehab, et al.
European Polymer Journal (2023) Vol. 190, pp. 111993-111993
Closed Access | Times Cited: 28
Neha Parveen, Afsana Sheikh, Mohammed A. S. Abourehab, et al.
European Polymer Journal (2023) Vol. 190, pp. 111993-111993
Closed Access | Times Cited: 28
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond
Xiaoling Fu, Urushi Rehman, Liuya Wei, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100935-100935
Closed Access | Times Cited: 24
Xiaoling Fu, Urushi Rehman, Liuya Wei, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100935-100935
Closed Access | Times Cited: 24
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 23
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 23
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
Zi‐Ning Lei, Najah Albadari, Qiu-Xu Teng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101065-101065
Closed Access | Times Cited: 10
Zi‐Ning Lei, Najah Albadari, Qiu-Xu Teng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101065-101065
Closed Access | Times Cited: 10
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Xiaodan Jia, Yue Wang, Yue Qiao, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 9
Xiaodan Jia, Yue Wang, Yue Qiao, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 9
Immunoliposomes as an emerging nanocarrier for breast cancer therapy
Neha Parveen, Mohammed A. S. Abourehab, Rahul Shukla, et al.
European Polymer Journal (2022) Vol. 184, pp. 111781-111781
Closed Access | Times Cited: 30
Neha Parveen, Mohammed A. S. Abourehab, Rahul Shukla, et al.
European Polymer Journal (2022) Vol. 184, pp. 111781-111781
Closed Access | Times Cited: 30
A review on lipid-polymer hybrid nanocarriers in cancer
Dipanjan Karati, Swarupananda Mukherjee, Bhupendra G. Prajapati, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105827-105827
Closed Access | Times Cited: 6
Dipanjan Karati, Swarupananda Mukherjee, Bhupendra G. Prajapati, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105827-105827
Closed Access | Times Cited: 6
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 16
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 16
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Preliminary Study of a Novel 68Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis
Shuyue Cai, Rui Tang, Jichen Yang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Shuyue Cai, Rui Tang, Jichen Yang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Hydrogel-based 3D printing technology: From interfacial engineering to precision medicine
Haojie Wu, Jibo Diao, Xinrong Li, et al.
Advances in Colloid and Interface Science (2025) Vol. 341, pp. 103481-103481
Closed Access
Haojie Wu, Jibo Diao, Xinrong Li, et al.
Advances in Colloid and Interface Science (2025) Vol. 341, pp. 103481-103481
Closed Access
A mitochondrial-targeted nanomedicine based on hollow mesoporous silica nanoparticles for enhanced colorectal cancer therapy
Jin Liu, Tianle Liu, Chi Zhang, et al.
Colloids and Interface Science Communications (2025) Vol. 66, pp. 100833-100833
Closed Access
Jin Liu, Tianle Liu, Chi Zhang, et al.
Colloids and Interface Science Communications (2025) Vol. 66, pp. 100833-100833
Closed Access
Decoding Allosteric Effects of Missense Variations in Drug Metabolism: Afrocentric CYP3A4 Alleles Explored
Rehema Mukami Mwaniki, Wayde Veldman, Allan Sanyanga, et al.
Journal of Molecular Biology (2025), pp. 169160-169160
Open Access
Rehema Mukami Mwaniki, Wayde Veldman, Allan Sanyanga, et al.
Journal of Molecular Biology (2025), pp. 169160-169160
Open Access
Injectable and implantable hydrogels for localized delivery of drugs and nanomaterials for cancer chemotherapy: A review
Manuel R Pouso, Bruna L. Melo, Joaquim J Gonçalves, et al.
International Journal of Pharmaceutics (2025), pp. 125640-125640
Open Access
Manuel R Pouso, Bruna L. Melo, Joaquim J Gonçalves, et al.
International Journal of Pharmaceutics (2025), pp. 125640-125640
Open Access
The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents
Shiwen Yu, Jinling Zheng, Yan Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117486-117486
Closed Access | Times Cited: 10
Shiwen Yu, Jinling Zheng, Yan Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117486-117486
Closed Access | Times Cited: 10
